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Abstract 
Review on t(5;11)(q35;q12) NSD1/FEN1, with data 
on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
Acute monocytic leukemia (AML-M5b) 
Epidemiology 
Four cases of acute myeloid leukemia with 
t(5;11)(q35;q12-13) are reported in the literature: 
two acute myeloblastic leukemia with 
differentiation (AML-M2) (Wang et al., 2006; de 
Oliveira et al., 2007), one acute myelomonocytic 
leukemia (AML-M4) (Itoh et al., 1999) and one 
acute monoblastic leukemia (AML-M5) (Leverger 
et al., 1988). No molecular characterization was 
performed in these cases but the NSD1 gene was 
shown not to be involved by fluorescent in situ 
hybridization in the AML-M2 case reported by 
Wang et al. (2006). 
Clinics 
A 37-year-old man seen because of throat infection 
resistant to antibiotics, persistent fever and dyspnea. 
Treatment 
Induction therapy and several salvage therapies 
failed to achieve complete remission followed by 
bone marrow transplantation. 
Evolution 
Patient alive in complete remission 35 months 
following bone marrow transplantation. 
Cytogenetics 
Note 
The t(5;11)(q35;q12) involves two genes of which 
one, the NSD1 gene, has been already shown to 
form a fusion gene with NUP98 in the 
t(5;11)(q35;p15.1) (Jaju et al., 2001). 
 
RHG banding showing chromosomes 5 and 11 and the 
derivatives der(5) and der(11). 
Cytogenetics morphological 
t(5;11)(q35;q12) is identified by banding 
cytogenetics. 
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FISH with BACs RP11-99N22 (spectrum orange, located in 5q35 and containing NSD1) and RP11-467L20 (spectrum green, 
located in 11q12 and containing FEN1) showing co-hybridization. 
 
Cytogenetics molecular 
To determine the position of the breakpoints on 
chromosomes 5 and 11, BACs located in the bands 
of interest were used as probes in FISH 
experiments.  
Analysis with RP11-99N22 showed that one signal 
hybridized to the normal chromosome 5, and the 
other split and hybridized to both der(5) and 
der(11).  
FISH with overlapping BACs identified a very 
small region of breakage in RP11-467L20. Analysis 
with RP11-467L20 showed that one signal 
hybridized to the normal chromosome 11, and the 
other split and hybridized to both der(11) and 
der(5).  
Co-hybridization with both BAC clones showed 
two fusion signals. RP11-99N22 contains the NSD1 
gene and RP11-467L20 the FEN1 gene. 
Genes involved and 
proteins 
NSD1 
Location 
5q35.3 
DNA/RNA 
The NSD1 gene contains 24 exons, of which 23 are 
coding, spanning 167 kb. Two alternative 
transcripts are known (Kurotaki et al., 2001). 
Protein 
The protein has 2696 amino acids and localizes to 
the nucleus. It contains a SET domain, 2 LXXLL 
motifs, 3 nuclear translocation signals, 4 plant 
homeodomain (PHD) finger regions, and a proline-
rich region. The protein acts as a basic 
transcriptional factor and also as a bifunctional 
transcriptional regulator, capable of both negatively 
or positively influencing transcription, depending 
on the cellular context (Huang et al., 1998; 
Kurotaki et al., 2001). 
FEN1 
Location 
11q12.2 
DNA/RNA 
The FEN1 gene contains 2 exons, of which a sole is 
coding, spanning 4 kb (Hiraoka et al., 1995). 
Protein 
The protein has 380 amino acids and localizes to 
the nucleus. It is a structure-specific nuclease with 
5'-flap endonuclease and 5'-3' exonuclease activities 
involved in DNA replication and repair. It acts as a 
genome stabilization factor that prevents flaps from 
equilibrating into structures that lead to duplications 
and deletions and participates in telomere 
maintenance (Saharia et al., 2008; Zheng et al., 
2011; Tsutakawa et al., 2011). It has been 
suggested that FEN1 is a tumor suppressor gene 
(Henneke et al., 2003). 
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